CAS: 729607-74-3
Ref: IN-DA00FBZL
| 1mg | 113,00 € | ||
| 5mg | 137,00 € | ||
| 25mg | 170,00 € | ||
| 50mg | 238,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
BMS-707035
CAS:729607-74-3
BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM. Phase 2.
Fórmula:
C17H19FN4O5S
Pureza:
99.78%
Forma y color:
Solid
Peso molecular:
410.42
Ref: TM-T6420
| 2mg | 40,00 € | ||
| 5mg | 59,00 € | ||
| 10mg | 95,00 € | ||
| 25mg | 183,00 € | ||
| 50mg | 335,00 € | ||
| 100mg | 546,00 € | ||
| 1mL*10mM (DMSO) | 67,00 € |
Entrega estimada en Estados Unidos, el Martes 14 de Enero de 2025
![N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2...](https://static.cymitquimica.com/products/3D/thumb/FF103761.jpg)
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin-2-yl)-4-pyrimidinecarboxami de
CAS:729607-74-3
N-[(4-Fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(tetrahydro-1,1-dioxido-2H-1,2-thiazin-2-yl)-4-pyrimidinecarboxami de (R7128) is an inhibitor of HIV integrase. It prevents HIV from replicating by …
Fórmula:
C17H19FN4O5S
Pureza:
Min. 95%
Peso molecular:
410.42 g/mol
Ref: 3D-FF103761
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
